Ignite Creation Date:
2025-12-25 @ 2:10 AM
Ignite Modification Date:
2025-12-29 @ 4:47 AM
Study NCT ID:
NCT06946160
Status:
COMPLETED
Last Update Posted:
2025-05-07
First Post:
2025-04-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Non-inferiority Clinical Trial to Compare Efficacy and Safety of Abobotulinumtoxin A (Espad Pharmed) Versus AbobotulinumtoxinA (Dysport®, Ipsen Co.) for Correction of Moderate to Severe Glabellar Lines
Sponsor:
Espad Pharmed
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-28
Start Date Type:
ACTUAL
Primary Completion Date:
2025-02-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-02-18
Completion Date Type:
ACTUAL
First Submit Date:
2025-04-19
First Submit QC Date:
None
Study First Post Date:
2025-04-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-04
Last Update Post Date:
2025-05-07
Last Update Post Date Type:
ACTUAL